Types of peptides &
what the research shows

A single molecule that acts on three receptors at once — GLP-1, GIP and glucagon. This triple-agonist profile has made it one of the most closely followed investigational compounds in metabolic research, and it has been the subject of clinical research programmes investigating metabolic endpoints. As an investigational compound, findings continue to develop within the conditions of each study.

A stabilised analogue of growth-hormone-releasing hormone (GHRH) and one of the few peptides here with regulatory approval for a specific clinical indication. It has been studied in clinical research for visceral adipose-tissue, liver-fat and cognition endpoints. Findings should be interpreted within the conditions of each study.

A 15-amino-acid sequence derived from a protein in gastric juice. It has been studied in numerous animal models for tissue-repair, angiogenesis and tissue-protection endpoints. Robust human clinical data does not yet exist, so these findings remain preclinical.

A synthetic fragment of Thymosin Beta-4, a natural repair protein. Preclinical studies have examined wound-closure, cell-migration and tissue-remodelling endpoints. The parent protein has been investigated in early clinical research for wound and corneal-healing endpoints.

A selective ghrelin-receptor agonist that stimulates a clean pulse of growth hormone with minimal effect on cortisol or prolactin in research models — which is why it's a common reference compound in GH-axis studies.

Combines a long-acting GHRH analogue with Ipamorelin. It is studied for GH-axis stimulation, with research examining growth-hormone and IGF-1 endpoints across two complementary pathways. Findings are drawn from the specific models of each study.

Derived from a fragment of ACTH. Research has examined its effects on BDNF (a key neurotrophic factor) and neuroprotective endpoints in models of ischaemia and oxidative stress. Findings are drawn from the specific research models of each study.

An analogue of the immunopeptide tuftsin. It is studied in neuroscience research for anxiety-related behavioural endpoints via the GABA system, alongside immune-modulating signalling. Findings are drawn from the specific models of each study.

A tetrapeptide studied for its effect on telomerase activity and telomere length. Long-running rodent studies, particularly from Russian gerontology research, have examined effects on circadian-regulation and ageing-related endpoints.

A peptide encoded within mitochondrial DNA that acts as a metabolic regulator. Preclinical work has examined its role in insulin-signalling, metabolic-adaptation and exercise-physiology endpoints in animal models.

Also known as elamipretide, this mitochondria-targeting peptide has been the subject of clinical research programmes examining cellular energy-production and oxidative-stress endpoints. Findings continue to develop within the conditions of each study.

An essential coenzyme involved in hundreds of metabolic reactions and in DNA repair. Because NAD+ levels decline substantially with age, it and its precursors are a major focus of longevity and metabolic research.

A copper-binding tripeptide found naturally in plasma. It is one of the best-studied peptides in skin science, with research examining collagen and elastin synthesis, skin-remodelling, wound-healing biology and antioxidant gene-expression endpoints. Findings are drawn from the specific models of each study.

A pre-combined blend pairing the cosmetic and repair peptides described above, researched for potential complementary effects on tissue and skin remodelling.